NICOLE GLICK: Open Payments
NPI 1700323227 · MISSION VIEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,253 in 61 payments from 18 companies in 2025. Trend: 2023 $893 · 2024 $600 · 2025 $1,253
Food & beverage: $1,253
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $183 |
| AstraZeneca Pharmaceuticals LP | 5 | $174 |
| Novo Nordisk Inc | 11 | $144 |
| Lilly USA, LLC | 7 | $98 |
| PFIZER INC. | 4 | $88 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| Corcept Therapeutics | 4 | $72 |
| Axsome Therapeutics, Inc. | 2 | $70 |
| Exact Sciences Corporation | 2 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
Products named: AIRSUPRA, VRAYLAR, REXULTI, Ozempic, UBRELVY, Korlym, Symbravo, Cologuard Collection Kit.
Industry payments across CA — which companies pay providers there.
